Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer

References

• SorlieTPerouCMTibshiraniRGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci U S A20019819108691087411553815
   PubMed Web of Science ®Google Scholar
• SorlieTTibshiraniRParkerJRepeated observation of breast tumor subtypes in independent gene expression data setsProc Natl Acad Sci U S A2003100148418842312829800
   PubMed Web of Science ®Google Scholar
• SotiriouCNeoSYMcshaneLMBreast cancer classification and prognosis based on gene expression profiles from a population-based studyProc Natl Acad Sci U S A200310018103931039812917485
   PubMed Web of Science ®Google Scholar
• RakhaEAEl-SayedMEGreenARLeeAHRobertsonJFEllisIOPrognostic markers in triple-negative breast cancerCancer20071091253217146782
   PubMed Web of Science ®Google Scholar
• CareyLADeesECSawyerLThe triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesClin Cancer Res20071382329233417438091
   PubMed Web of Science ®Google Scholar
• Reis-FilhoJSTuttANTriple negative tumours: a critical reviewHistopathology200852110811818171422
   PubMed Web of Science ®Google Scholar
• CleatorSHellerWCoombesRCTriple-negative breast cancer: therapeutic optionsLancet Oncol20078323524417329194
   PubMed Web of Science ®Google Scholar
• Lara-MedinaFPerez-SanchezVSaavedra-PerezDTriple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parityCancer2011117163658366921387260
   PubMed Web of Science ®Google Scholar
• Vona-DavisLRoseDPHazardHTriple-negative breast cancer and obesity in a rural Appalachian populationCancer Epidemiol Biomarkers Prev200817123319332419064545
   PubMed Web of Science ®Google Scholar
• KwanMLKushiLHWeltzienEEpidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivorsBreast Cancer Res2009113R3119463150
   PubMed Web of Science ®Google Scholar
• NielsenTOHsuFDJensenKImmunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaClin Cancer Res200410165367537415328174
   PubMed Web of Science ®Google Scholar
• Metzger-FilhoOTuttADe AzambujaEDissecting the heterogeneity of triple-negative breast cancerJ Clin Oncol201230151879188722454417
   PubMed Web of Science ®Google Scholar
• Chainani-WuNSafety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa)J Altern Complement Med20039116116812676044
   PubMed Web of Science ®Google Scholar
• ChengALHsuCHLinJKPhase I clinical trial of curcumin, a chemo-preventive agent, in patients with high-risk or pre-malignant lesionsAnticancer Res2001214B2895290011712783
   PubMed Web of Science ®Google Scholar
• AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
   PubMed Web of Science ®Google Scholar
• YadavBTaurinSRosengrenRJSynthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcuminBioorg Med Chem201018186701670720728364
   PubMed Web of Science ®Google Scholar
• YadavBTaurinSLarsenLRosengrenRJRL66 a second generation curcumin analog has potent in vivo and in vitro anticancer activity in ER negative breast cancer modelsInt J Oncol20124151723173222971638
   PubMed Web of Science ®Google Scholar
• YadavBTaurinSLarsenLRosengrenRJRL71, a second generation curcumin analog, induces apoptosis and down regulates AKT in ER-negative breast cancer cellsInt J Oncol20124131119112722710975
   PubMed Web of Science ®Google Scholar
• HutzenBFriedmanLSoboMCurcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomasInt J Oncol200935486787219724924
   PubMed Web of Science ®Google Scholar
• LinLHutzenBBallSNew curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cellsCancer Sci200910091719172719558577
   PubMed Web of Science ®Google Scholar
• KasinskiALDuYThomasSLInhibition of IkappaB kinase- nuclear factor-kappaB signaling pathway by 3,5-bis(2-urobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcuminMol Pharmacol200874365466118577686
   PubMed Web of Science ®Google Scholar
• Somers-EdgarTJTaurinSLarsenLChandramouliANelsonMARosengrenRJMechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell linesInvest New Drugs2011291879719816657
   PubMed Web of Science ®Google Scholar
• SongZFengRSunMCurcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: preparation, pharmacokinetics and distribution in vivoJ Colloid Interface Sci2011354111612321044788
   PubMed Web of Science ®Google Scholar
• RahmanSCaoSSteadmanKJWeiMParekhHSNative and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancerDrug Deliv201219734635323030405
   PubMed Web of Science ®Google Scholar
• YangRZhangSKongDGaoXZhaoYWangZBiodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcuminPharm Res201229123512352522961588
   PubMed Web of Science ®Google Scholar
• MaedaHMatsumuraYTumoritropic and lymphotropic principles of macromolecular drugsCrit Rev Ther Drug Carrier Syst1989631932102692843
   PubMed Web of Science ®Google Scholar
• GreishKFangJInutsukaTNagamitsuAMaedaHMacromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targetingClin Pharmacokinet2003421310891105
   PubMed Web of Science ®Google Scholar
• MaedaHTakeshitaJKanamaruRA lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibioticInt J Pept Protein Res19791428187158571
   PubMedGoogle Scholar
• MaedaHBharateGYDaruwallaJPolymeric drugs for efficient tumor-targeted drug delivery based on EPR-effectEur J Pharm Biopharm200971340941919070661
   PubMed Web of Science ®Google Scholar
• TaurinSNehoffHDiongJLarsenLRosengrenRJGreishKCurcumin-derivative nanomicelles for the treatment of triple negative breast cancerJ Drug Target201321767568323679865
   PubMed Web of Science ®Google Scholar
• ScandlynMJStuartECSomers-EdgarTJMenziesARRosengrenRJA new role for tamoxifen in estrogen receptor negative breast cancer when it is combined with epigallocatechin gallateBr J Cancer20089971056106318797454
   PubMed Web of Science ®Google Scholar
• HornTHenriksenJHChristoffersenPThe sinusoidal lining cells in “normal” human liver. A scanning electron microscopic investigationLiver198662981103736357
   PubMedGoogle Scholar
• SarinHPhysiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeabilityJ Angiogenes Res201021420701757
   PubMedGoogle Scholar
• RamasamyTRuttalaHBGuptaBSmart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive reviewJ Control Release201725822625328472638
   PubMed Web of Science ®Google Scholar
• WangLZhangDZWangYXBioflavonoid fisetin loaded alpha-to-copherol-poly(lactic acid)-based polymeric micelles for enhanced anticancer efficacy in breast cancersPharm Res201734245346128004315
   PubMed Web of Science ®Google Scholar
• RuttalaHBRamasamyTPoudalBKMolecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapyOncotarget201789149251494028122339
   PubMedGoogle Scholar
• BishtSSchlesingerMRuppAA liposomal formulation of the synthethetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapiesJ Nanobiotechnol201614157
   PubMedGoogle Scholar
• ChoiHSLiuWLiuFDesign considerations for tumour-targeted nanoparticlesNat Nanotechnol201051424719893516
   PubMed Web of Science ®Google Scholar
• DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• YangBZhangMGaoJSmall molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancerOncotarget2015635376133762526608678
   PubMedGoogle Scholar
• AllamANKomeilIAFoudaMAAbdallahOYPreparation, characterization and in vivo evaluation of curcumin self-nano phospholipid dispersion as an approach to enhance oral bioavailabilityInter J Pharm20154891–2117123
   PubMedGoogle Scholar
• WangJMaWTuPThe mechanism of self-assembled mixed micelles in improving curcumin oral absorption: in vitro and in vivoColloids Surface B Biointerfaces2015133108119
   PubMed Web of Science ®Google Scholar
• SzymusiakMHuXLeon PlataPACiupinskiPWangZJLiuYBioavailability of curcumin and cucumin glucuronide in the central nervous system of mice after oral delivery of nano-curuminInt J Pharm2016511141542327426105
   PubMedGoogle Scholar
• RanjanAPMukerjeeAGdowskiMACurcumin-ER prolonged subcutaneous delivery for the treatment of non-small cell lung cancerJ Biomed Nanotechnol201612467968827301194
   PubMed Web of Science ®Google Scholar
• YuanAYangPCYuCJTumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancerAm J Respir Crit Care Med19951526 Pt 1215721628520790
   PubMed Web of Science ®Google Scholar
• HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: role of tumor type and microenvironmentProc Natl Acad Sci U S A1998958460746129539785
   PubMed Web of Science ®Google Scholar
• TaurinSNehoffHGreishKAnticancer nanomedicine and tumor vascular permeability; Where is the missing link?J Control Release2012164326527522800576
   PubMed Web of Science ®Google Scholar
• UchinoHMatsumuraYNegishiTCisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in ratsBr J Cancer200593667868716222314
   PubMed Web of Science ®Google Scholar
• CuiTZhangSSunHCo-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatmentOncol Report201737212531260
   PubMed Web of Science ®Google Scholar
• YanJWangYZhnagXLiuSTianCWangHTargeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivoDrug Deliv20162351757176226203689
   PubMed Web of Science ®Google Scholar
• PhanQTLeMHLeTTTranTHXuanPNHaPTCharacteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratiosInter J Pharm20165073240
   PubMed Web of Science ®Google Scholar